fda semaglutide shortage lawsuit ofa As of February 21, 2025, the updated its drug list, marking FDA backtracks over Eli Lilly

However, it is important to inform a healthcare professional if these side effects persist or worsen

A Phase 2 study published in 2023 reported dose-dependent reductions in body weight among trial participants, with the highest dose associated with reductions of up to roughly 24% over 48 weeks

Establish medical record review protocols now

Quick Answer: Retatrutide has no current US price because it isnt FDA approved as of May 2026 Tirzepatide pen prices when introduced: Mounjaro (T2D label): ,069.08 per month list Zepbound (obesity label): ,059.87 per month list Lilly priced both tirzepatide formulations to undercut Wegovy (semaglutide 2.4 mg at ,349 list) by about 20 percent

Thyroid concerns or other conditions that affect weight

Whats next for SWMPs